NCT07080970
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- SOD Ematologia, Università di Firenze, AOU Careggi Florence, Italy
Clinical trial condition
NPM1 Mutation
Explore clinical trials studying NPM1 Mutation. Study availability and eligibility vary by location and protocol.
8 public trials
6 recruiting studies
NPM1 Mutation trial results
Recruiting
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
NCT07559695
- Conditions
- Acute Leukemia, KMT2A Rearrangement, Maintenance Therapy, +4 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT06001788
- Conditions
- AML, AML With Mutated NPM1, Acute Leukemia, +14 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCLA Health - Bowyer Oncology Center Los Angeles, California, United States
- UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
Recruiting
Ziftomenib Maintenance Post Allo-HCT
NCT06440135
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Hematologic Diseases, +8 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Ohio State University Wexner Medical Center- James Cancer Hospital Columbus, Ohio, United States
NCT05735184
- Conditions
- AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, +19 more
- Locations
-
- Mayo Clinic - Phoenix Phoenix, Arizona, United States
- Moores UC San Diego Cancer Center La Jolla, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCLA - Bowyer Oncology Center Los Angeles, California, United States
NCT07101497
- Conditions
- Acute Leukemia, KMT2A Rearrangement, Maintenance Therapy, +4 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Not Yet Recruiting
Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations
NCT07664839
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Active, Not Recruiting
A Study of BN104 in the Treatment of Acute Leukemia
NCT06052813
- Conditions
- ALL, Adult, AML, Adult, Acute Leukaemia, +17 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, China